Drugs Made in America Acquisition Corp. (Ticker: DMAAU US) is a blank-check company focused on acquisitions in the pharmaceutical industry. The company will list on January 10, 2025 on the NASDAQ Global Market. The firm is offering 20 million units at an expected price of $10.00 per unit, aiming to raise $200 million. Each unit consists of one share and one right.

The total offer size is $200 million, with an expected market capitalization at offer of $406.44 million. The offering is managed by Clear Street LLC. The company has a 15% greenshoe option, which could increase the offer by an additional 3 million units if exercised.